Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

XOMA

XOMA (XOMA)

XOMA Corporation

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:XOMA

1 2 3 4 5 6 7 8 9 10 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
30/04/2024	13h30	GlobeNewswire Inc.	XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%	NASDAQ:XOMA	XOMA Corporation
25/04/2024	13h30	GlobeNewswire Inc.	XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMA	XOMA Corporation
24/04/2024	15h00	PR Newswire (US)	Actym Therapeutics Appoints Thomas Smart as CEO	NASDAQ:XOMA	XOMA Corporation
03/04/2024	15h00	GlobeNewswire Inc.	XOMA Corporation Announces Closing of Tender Offer	NASDAQ:XOMA	XOMA Corporation
21/03/2024	12h30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
19/03/2024	21h05	GlobeNewswire Inc.	XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.	NASDAQ:XOMA	XOMA Corporation
08/03/2024	13h30	GlobeNewswire Inc.	XOMA Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent and Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMA	XOMA Corporation
28/02/2024	13h30	GlobeNewswire Inc.	XOMA to Present at Upcoming Investor Conferences in March	NASDAQ:XOMA	XOMA Corporation
16/02/2024	14h00	GlobeNewswire Inc.	XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right	NASDAQ:XOMA	XOMA Corporation
18/01/2024	14h30	GlobeNewswire Inc.	XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisition	NASDAQ:XOMA	XOMA Corporation
11/01/2024	22h50	Dow Jones News	Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	NASDAQ:XOMA	XOMA Corporation
11/01/2024	22h05	GlobeNewswire Inc.	FDA Acceptance of Zevra’s Arimoclomol NDA Filing for Niemann-Pick Disease Type C (NPC) Results in XOMA Making a $1 Million Milestone Payment to LadRx	NASDAQ:XOMA	XOMA Corporation
08/01/2024	13h30	GlobeNewswire Inc.	XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors	NASDAQ:XOMA	XOMA Corporation
02/01/2024	13h30	GlobeNewswire Inc.	XOMA Announces Stock Repurchase Program of up to $50 Million	NASDAQ:XOMA	XOMA Corporation
20/12/2023	13h30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
19/12/2023	13h30	GlobeNewswire Inc.	XOMA Raises up to $140 Million in Non-Dilutive, Non-Recourse Financing from Funds Managed by Blue Owl Capital Backed by VABYSMO® Royalties	NASDAQ:XOMA	XOMA Corporation
07/11/2023	13h30	GlobeNewswire Inc.	XOMA Reports Third Quarter 2023 Financial Results and Highlights Upcoming Events Expected to Drive Shareholder Value	NASDAQ:XOMA	XOMA Corporation
31/10/2023	12h30	GlobeNewswire Inc.	XOMA Earns $5 Million Milestone Upon FDA Acceptance of Day One’s Tovorafenib NDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)	NASDAQ:XOMA	XOMA Corporation
25/09/2023	13h30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
06/09/2023	13h30	GlobeNewswire Inc.	XOMA to Present at H.C. Wainwright 25th Annual Global Investment Conference	NASDAQ:XOMA	XOMA Corporation
08/08/2023	13h30	GlobeNewswire Inc.	XOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategy	NASDAQ:XOMA	XOMA Corporation
24/06/2023	00h14	GlobeNewswire Inc.	XOMA Added to the Russell 2000® and Russell 3000® Indexes	NASDAQ:XOMA	XOMA Corporation
22/06/2023	13h30	GlobeNewswire Inc.	XOMA Acquires Royalty and Milestone Economics to Phase 3 First-In-Class Orphan Disease Asset for Niemann-Pick Disease Type C (NPC) and Phase 2 Oncology Asset	NASDAQ:XOMA	XOMA Corporation
20/06/2023	13h30	GlobeNewswire Inc.	XOMA Declares Quarterly Preferred Stock Dividends	NASDAQ:XOMA	XOMA Corporation
25/05/2023	22h34	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
22/05/2023	22h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
22/05/2023	22h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
19/05/2023	23h04	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
19/05/2023	22h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation
19/05/2023	22h31	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:XOMA	XOMA Corporation

Showing the most relevant articles for your search:NASDAQ:XOMA

1 2 3 4 5 6 7 8 9 10 Next >>

Health Care Select Sector

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen